- Proportionate EBITDAF: $506 million for the half, a 7% increase on a like-for-like basis compared to the previous period.
- Proportionate Development EBITDAF: Loss of $28 million.
- Proportionate CapEx: Increased by 50% to $1.2 billion.
- Interim Dividend: $0.0725 per share, unimputed.
- CDC EBITDAF: On track, with significant demand growth and customer negotiations.
- One NZ EBITDAF: $304 million, a 9% increase from the prior period.
- One NZ EBITDAF Margin: 32%, up from 30% in FY24.
- One NZ Operating Free Cash Flows: $117 million, up $21 million from the comparable period.
- Longroad Energy EBITDAF: Down compared to the same half last year due to previous high prices.
- Diagnostic Imaging Earnings Growth: On track for double-digit growth despite cost pressures.
- CapEx Guidance: Revised to $2.4 billion to $2.8 billion.
- Debt Facilities and Liquidity: Improved financial flexibility following the June equity raise.
- Warning! GuruFocus has detected 12 Warning Signs with ASX:IFT.
Release Date: November 13, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- Infratil Ltd (ASX:IFT) reported a strong operating performance across its portfolio, despite challenging market conditions.
- CDC Data Centres, the company's largest investment, continues to experience significant demand growth, leading to ongoing investment in construction and securing power and land for future projects.
- One NZ performed well, aligning with guidance and making substantial progress on strategic priorities, contributing to a 9% increase in EBITDAF.
- The merger of Manawa Energy and Contact Energy was announced at a significant premium, with expected strong benefits for both companies.
- Infratil Ltd (ASX:IFT) completed a successful equity raise in June, enhancing balance sheet flexibility to support growth and shareholder value creation.
Negative Points
- Uncertainty from the US election results poses a potential headwind for Longroad Energy, particularly concerning tariffs and green policies.
- The investment in Console Connect was canceled, which was disappointing as the company remains positive about global next-generation connectivity platforms.
- Proportionate development EBITDAF reported a loss of $28 million, highlighting challenges in development expenditure.
- CDC Data Centres is trending towards the lower end of its guidance range due to shifts in project timelines.
- The Commerce Commission charges against One NZ could pose legal and financial challenges, although the company intends to challenge the charges vigorously.
Q & A Highlights
Q: Regarding CDC, has the timeline for the 388 megawatts online by the end of FY26 changed, and does this affect the EBITDA outlook? A: The timeline for the 388 megawatts remains unchanged, and we still expect strong EBITDA growth in FY26. Some workloads have shifted, but the overall completion timeline is intact.
Q: Can you clarify the potential impact on CDC's contracted EBITDA if the 300 megawatts are signed pre-Christmas? A: There will be some modest reservation, but we expect the capacity to come online as planned. The EBITDA per megawatt might dip slightly below $2 million but should trend back up over time.
Q: Are there any participation rights for Infratil in the partial sale process for CDC if the price is high? A: We do not have any participation rights in the sale process, but we are closely monitoring the situation.
Q: With the US election outcomes, is there a risk of delay in Longroad Energy's 9.5 gigawatts capacity target by 2027? A: The 9.5 gigawatts target may be high given current yields. We are focusing on value creation per year, and while delays are possible, especially post-election, we are working to mitigate these risks.
Q: Regarding One NZ, is there potential for further efficiencies, and how does the company plan to handle competitive pricing pressures? A: Yes, further efficiencies are possible, particularly through IT transformation. We do not intend to follow the market down on pricing, focusing instead on providing high-quality offerings and maintaining a long-term focus.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on
GuruFocus.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.